Helsinn announces publication of anamorelin ROMANA 1 and ROMANA 2 Phase III studies in The Lancet Oncology

24 March 2016

Helsinn presents Quality of Life, its first group sustainability report

24 March 2016

Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise

21 March 2016

Cerbios-Pharma SA Celebrating 40 Years of Biological activities

11 March 2016

HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH MUNDIPHARMA

25 February 2016

Cerbios’ new R&D Centre for HPAI and mAb development officially opened

23 February 2016

HELSINN CELEBRATES ITS 40th ANNIVERSARY

11 January 2016